SHARE:  

Wednesday, September 25, 2024

12:00PM-1:00PM

In person or Via Zoom

https://partners.zoom.us/j/5823462701

*Participant Instructions

Uncovering a regulatory network that determines homeostatic versus proinflammatory Th17 cell state

Ana Carrizosa Anderson, Ph.D.

Professor of Neurology, Harvard Medical School

Senior Scientist at Brigham and Women’s Hospital

Core Faculty, The Gene Lay Institute of Immunology and Inflammation

Institute Member, Broad Institute

Harvard Medical School and Brigham and Women's Hospital



Dr. Anderson is a Professor of Neurology at Harvard Medical School, Senior Scientist at the Brigham and Women’s Hospital, Institute Member of the Broad Institute of MIT and Harvard, Core Faculty of the Gene Lay Institute of Immunology and Inflammation, and Co-Chair of the Infectious and Immunologic Diseases Program at the Brigham Research Institute. She obtained her B.S. in Microbiology and Immunology in 1993 from the University of Miami, where she graduated summa cum laude. She obtained her Ph.D. in Immunology from Harvard University in 1999. During her Ph.D., she was awarded a fellowship from the Howard Hughes Medical Institute. Dr. Anderson works in the fields of autoimmunity and cancer immunology. Her laboratory identified that the co-inhibitory molecule Tim-3 is a key regulator of T cell dysfunction in cancer and has identified gene programs associated with activated, dysfunctional, and stem-like CD8+ T cell states in cancer. Dr. Anderson has published over 65 original papers, 24 reviews, and 5 book chapters. She has been recognized as a Highly Cited Researcher in Immunology with multiple papers ranking in the top 1% of her field every year since 2020. Her work on T cell cross-reactivity in autoimmunity was selected by Nature Immunology as a ‘Classic Paper in Autoimmunity’. She has also had several papers selected as either ‘must-read’ or ‘recommended’ by the Faculty of 1000. Dr. Anderson is on the editorial board for OncoImmunology and The Journal for Immunotherapy of Cancer. She currently serves on the scientific advisory boards for Tizona Therapeutics, Trishula Therapeutics, Compass Therapeutics, Zumutor Biologics, and Excepgen. Dr. Anderson’s research is funded by the NIH, non-profit foundations, and company sponsored research agreements.

Join in person in the Wolf Conference Center or via Zoom https://partners.zoom.us/j/5823462701


*Lunch will be served for in-person attendees


Steps to claim CME credits for BWH Neurology Grand Rounds:

Send code NAPQUN to 1-857-214-2277.

For more information about BWH Neurology Grand Rounds 2023-2024 click here

If you have any questions about the process for receiving CME credit, please contact the MGB Office of Continuing Professional Development (CPD) at PartnersCPD@partners.org or visit their website here.


Recordings of past seminars



October 2, 2024

No Neurology Grand Rounds- Neurology Faculty Meeting scheduled for October 1, 2024.

 

October 9, 2024

Martin A. Samuels, M.D. Memorial Lecture

Page Pennell, M.D., FAES, FAAN, FANA

Balancing Maternal Health with Fetal Risks when Prescribing Anti-Seizure Medications in Epilepsy: An Evidence-Based Approach

For questions and to submit feedback, please contact Seminar Directors Tracy Young-Pearse, Ph.D. and William R. Renthal, M.D., Ph.D.

To subscribe to Neurology Grand Rounds distribution list please click here.